Status:
COMPLETED
Biodegradable Airway Stent Post Lung Transplant
Lead Sponsor:
University Medical Center Groningen
Collaborating Sponsors:
AIDS Malignancy Consortium
Conditions:
Airway Complications Post Lung Transplant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Introduction and rationale Benign airway stenosis or malacia is a frequent complication of lung transplantation occurring in 4-24% of patients, most often occurring two to nine months post-transplant...
Detailed Description
* Background Recurrent airway stenosis or malacia can be treated with airway stents. Conventional airway stents, for instance self-extendable metallic stent (SEMS) and silicone stent are associated wi...
Eligibility Criteria
Inclusion
- Patients who underwent a lung transplantation and developed airway stenosis or malacia with airway stent requirement
Exclusion
- No
Key Trial Info
Start Date :
April 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05334199
Start Date
April 2 2019
End Date
March 31 2022
Last Update
April 27 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
AMC
Amsterdam, Netherlands
2
UMCG
Groningen, Netherlands